{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:13:30Z","timestamp":1780593210076,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.path.2025.08.008","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:42:14Z","timestamp":1764074534000},"page":"131-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blastic Plasmacytoid Dendritic Cell Neoplasm"],"prefix":"10.1016","volume":"19","author":[{"given":"Gabriel K.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Sadigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2025.08.008_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.path.2025.08.008_bib2","first-page":"941","article-title":"CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells","volume":"88","author":"Jacob","year":"2003","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.path.2025.08.008_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.2022017865","article-title":"North American blastic plasmacytoid dendritic cell neoplasm consortium: position on standards of care and areas of need","volume":"141","author":"Pemmaraju","year":"2023","journal-title":"Blood"},{"issue":"7966","key":"10.1016\/j.path.2025.08.008_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-023-06156-8","article-title":"Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin","volume":"618","author":"Griffin","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.path.2025.08.008_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2019001144","article-title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","volume":"134","author":"Taylor","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjd.12412","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients","volume":"169","author":"Julia","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.hoc.2020.01.010","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical presentation and diagnosis","volume":"34","author":"Deconinck","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.path.2025.08.008_bib8","article-title":"Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement","author":"Gera","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1016\/j.path.2025.08.008_bib9","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/bloodadvances.2024012797","article-title":"Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival","volume":"8","author":"Shimony","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaad.2024.11.010","article-title":"Blastic plasmacytoid dendritic cell neoplasm: extensive disease, Langer lines, and blood burden in a retrospective study of 66 cases","volume":"92","author":"Fay","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hoc.2020.01.001","article-title":"Blastic plasmacytoid dendritic cell neoplasm: the dermatologist\u2019s perspective","volume":"34","author":"Hirner","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"issue":"14","key":"10.1016\/j.path.2025.08.008_bib12","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/bloodadvances.2020001875","article-title":"Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant","volume":"4","author":"Yun","year":"2020","journal-title":"Blood Adv"},{"issue":"19","key":"10.1016\/j.path.2025.08.008_bib13","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","article-title":"Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients","volume":"4","author":"Laribi","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"121","author":"Roos-Weil","year":"2013","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.path.2025.08.008_bib15","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2020.01.007","article-title":"Novel therapies for blastic plasmacytoid dendritic cell neoplasm","volume":"34","author":"Lane","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"issue":"6","key":"10.1016\/j.path.2025.08.008_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.2024024262","article-title":"How I treat blastic plasmacytoid dendritic cell neoplasm","volume":"145","author":"Kharfan-Dabaja","year":"2025","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2025.08.008_bib18","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41375-018-0154-5","article-title":"Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response","volume":"32","author":"Sakamoto","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2025.08.008_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.leukres.2018.01.013","article-title":"8q24\/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms","volume":"66","author":"Boddu","year":"2018","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1309\/AJCP9IS9KFSVWKGH","article-title":"Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm","volume":"137","author":"Cronin","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.08.008_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cyto.b.21745","article-title":"CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping","volume":"96","author":"Bras","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.path.2025.08.008_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cyto.b.20469","article-title":"CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells","volume":"76","author":"Reineks","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcp\/aqac174","article-title":"Expanding the immunophenotypic spectrum of neoplastic and reactive plasmacytoid dendritic cells","volume":"159","author":"Wu","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.path.2025.08.008_bib24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual Expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2025.08.008_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","article-title":"Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm","volume":"106","author":"Wang","year":"2021","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.path.2025.08.008_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/PAS.0b013e31825dd4de","article-title":"Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases","volume":"36","author":"Vitte","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2025.08.008_bib27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/PAS.0000000000001960","article-title":"Plasmacytoid dendritic cell dermatosis associated to myeloproliferative\/myelodysplastic neoplasms","volume":"46","author":"Machan","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2025.08.008_bib28","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1182\/bloodadvances.2023012489","article-title":"Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms","volume":"8","author":"Mahevas","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.path.2025.08.008_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia","volume":"137","author":"Xiao","year":"2021","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.path.2025.08.008_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143375","article-title":"Immunophenotypic and molecular features of acute myeloid leukemia with plasmacytoid dendritic cell differentiation are distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.hoc.2020.01.003","article-title":"Cytogenetics of blastic plasmacytoid dendritic cell neoplasm: chromosomal rearrangements and DNA Copy-Number Alterations","volume":"34","author":"Sakamoto","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/bloodadvances.2020003359","article-title":"Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis","volume":"5","author":"Renosi","year":"2021","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.path.2025.08.008_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174132","article-title":"Genetics and epigenetics in neoplasms with plasmacytoid dendritic cells","volume":"14","author":"Renosi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.path.2025.08.008_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2018.09.006","article-title":"Genomic aberrations involving 12p\/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events","volume":"73","author":"Tang","year":"2018","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.path.2025.08.008_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1684\/ejd.2012.1663","article-title":"Loss of genomic DNA copy numbers in the p18, p16, p27 and RB loci in blastic plasmacytoid dendritic cell neoplasm","volume":"22","author":"Oiso","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/his.13668","article-title":"An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality","volume":"73","author":"Sumarriva","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2025.08.008_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/leu.2017.101","article-title":"Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm","volume":"31","author":"Suzuki","year":"2017","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.path.2025.08.008_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.183889","article-title":"BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid-dendritic cell leukemia","volume":"9","author":"Booth","year":"2024","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","volume":"96","author":"Tzankov","year":"2017","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.path.2025.08.008_bib40","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","article-title":"Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities","volume":"109","author":"Dijkman","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2025.08.008_bib41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Menezes","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.path.2025.08.008_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3324\/haematol.2018.202093","article-title":"Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target","volume":"104","author":"Sapienza","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","article-title":"Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients","volume":"36","author":"Khanlari","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.path.2025.08.008_bib44","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/leu.2017.38","article-title":"Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin","volume":"31","author":"Brunetti","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.path.2025.08.008_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-018-0120-5","article-title":"Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms","volume":"8","author":"Patnaik","year":"2018","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.path.2025.08.008_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100352","article-title":"Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow","volume":"37","author":"Sadigh","year":"2024","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.08.008_bib47","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1080\/10428194.2020.1755856","article-title":"Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone","volume":"61","author":"Luskin","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"10.1016\/j.path.2025.08.008_bib48","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.22.00034","article-title":"Long-term benefits of tagraxofusp for patients with blastic plasmacytoid dendritic cell neoplasm","volume":"40","author":"Pemmaraju","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.path.2025.08.008_bib49","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/bloodadvances.2021006645","article-title":"Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD","volume":"6","author":"Pemmaraju","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.path.2025.08.008_bib50","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1002\/ajh.26417","article-title":"Venetoclax and hypomethylating agents in older\/unfit patients with blastic plasmacytoid dendritic cell neoplasm","volume":"97","author":"Gangat","year":"2022","journal-title":"Am J Hematol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:47:53Z","timestamp":1770223673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918125000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1875918125000571"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2025.08.008","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blastic Plasmacytoid Dendritic Cell Neoplasm","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2025.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}